Exact Mass: 627.2316

Exact Mass Matches: 627.2316

Found 12 metabolites which its exact mass value is equals to given mass value 627.2316, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

3'-Deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin

6,8-dihydroxy-10-{[5-hydroxy-4-(2-methoxymorpholin-4-yl)-6-methyloxan-2-yl]oxy}-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione

C32H37NO12 (627.2316)


   

Pirarubicin

10-{[4-amino-6-methyl-5-(oxan-2-yloxy)oxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione

C32H37NO12 (627.2316)


   

tetrahydropyranyl adriamycin

10-[(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy]-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-2-(oxan-2-yl)-5,7,8,9,10,12-hexahydrotetracene-5,12-dione

C32H37NO12 (627.2316)


   
   

1alpha,15-diacetoxy-9alpha-benzoyloxy-4beta,6beta,8beta-trihydroxy-2alpha-nicotinoyloxy-dihydro-beta-agarofuran

1alpha,15-diacetoxy-9alpha-benzoyloxy-4beta,6beta,8beta-trihydroxy-2alpha-nicotinoyloxy-dihydro-beta-agarofuran

C32H37NO12 (627.2316)


   

Pirarubicin

(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-6-methyl-5-[(2S)-oxan-2-yl]oxyoxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione

C32H37NO12 (627.2316)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances D000970 - Antineoplastic Agents C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent

   

7-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-3-(oxan-2-yl)-8,10-dihydro-7H-tetracene-5,12-dione

7-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-3-(oxan-2-yl)-8,10-dihydro-7H-tetracene-5,12-dione

C32H37NO12 (627.2316)


   

9,11-dihydroxy-9-(2-hydroxyacetyl)-7-[5-hydroxy-4-(2-methoxymorpholin-4-yl)-6-methyloxan-2-yl]oxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione

9,11-dihydroxy-9-(2-hydroxyacetyl)-7-[5-hydroxy-4-(2-methoxymorpholin-4-yl)-6-methyloxan-2-yl]oxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione

C32H37NO12 (627.2316)


   

(7S,9S)-7-[[(2R,4S,5S,6S)-4-amino-6-methyl-5-[[(2R)-2-oxanyl]oxy]-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione

(7S,9S)-7-[[(2R,4S,5S,6S)-4-amino-6-methyl-5-[[(2R)-2-oxanyl]oxy]-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione

C32H37NO12 (627.2316)


   

4-(dimethylamino)-2,4-dimethyl-6-[(3,10,12-trihydroxy-2,7-dimethoxy-3-methyl-4,6,11-trioxo-1,2-dihydrotetracen-1-yl)oxy]oxan-3-yl acetate

4-(dimethylamino)-2,4-dimethyl-6-[(3,10,12-trihydroxy-2,7-dimethoxy-3-methyl-4,6,11-trioxo-1,2-dihydrotetracen-1-yl)oxy]oxan-3-yl acetate

C32H37NO12 (627.2316)


   

(2s,3s,4s,6s)-4-(dimethylamino)-2,4-dimethyl-6-{[(1r,2r,3r)-3,10,12-trihydroxy-2,7-dimethoxy-3-methyl-4,6,11-trioxo-1,2-dihydrotetracen-1-yl]oxy}oxan-3-yl acetate

(2s,3s,4s,6s)-4-(dimethylamino)-2,4-dimethyl-6-{[(1r,2r,3r)-3,10,12-trihydroxy-2,7-dimethoxy-3-methyl-4,6,11-trioxo-1,2-dihydrotetracen-1-yl]oxy}oxan-3-yl acetate

C32H37NO12 (627.2316)


   

(2s,3r,4r,6r)-4-(dimethylamino)-2,4-dimethyl-6-{[(1r,2r,3r)-3,10,12-trihydroxy-2,7-dimethoxy-3-methyl-4,6,11-trioxo-1,2-dihydrotetracen-1-yl]oxy}oxan-3-yl acetate

(2s,3r,4r,6r)-4-(dimethylamino)-2,4-dimethyl-6-{[(1r,2r,3r)-3,10,12-trihydroxy-2,7-dimethoxy-3-methyl-4,6,11-trioxo-1,2-dihydrotetracen-1-yl]oxy}oxan-3-yl acetate

C32H37NO12 (627.2316)